The Society for Cardiovascular Angiography and Interventions (SCAI) has launched a free eBook resource to help interventional cardiologists, cardiac imaging specialists, and clinicians learn the ins and outs of transcatheter tricuspid edge-to-edge repair (T-TEER). This minimally invasive procedure is aimed at treating tricuspid regurgitation, and Abbott’s TriClip device, approved by the FDA in April 2024, is the first T-TEER device on the market.
Key Insights:
- T-TEER Overview: T-TEER offers a new approach for tricuspid valve repair, with Abbott’s TriClip device leading the charge. A decision from the U.S. Centers for Medicare and Medicaid Services (CMS) on national coverage for T-TEER is expected soon.
- Comprehensive Resource: The eBook offers a comprehensive guide to T-TEER best practices, compiled from expert insights across Europe and North America. The publication provides a roadmap for the global adoption of this therapy, focusing on safety and efficacy.
- Challenges in Imaging: The eBook highlights the unique challenges of imaging the tricuspid valve, a key part of T-TEER procedures. Experts share techniques for optimizing echocardiographic imaging, which is critical to successful procedures.
Dr. Jason H. Rogers, a co-author of the guide, emphasized the importance of providing clinicians worldwide with access to the best resources. This initiative aims to improve procedural success rates and patient outcomes, ensuring a safer experience for those undergoing T-TEER.
Follow MEDWIRE.AI for further updates on interventional cardiology and emerging heart therapies.
